홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

픽산트론

Pixantrone

HCID 134019
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
144510-96-3
표준 SMILES
NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O
InChIKey
PEZPMAYDXJQYRV-UHFFFAOYSA-N
분자식
C17H19N5O2
평균 분자량
325.4 g/mol
단동위원소 질량
325.15387485

개요

Pixantrone is a member of isoquinolines.

이름 및 식별자

우선 이름
Pixantrone
IUPAC
6,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione
현지명
픽산트론
영어명
Pixantrone
분자식
C17H19N5O2
분자량
325.37

이름 및 동의어

Pixantrone144510-96-36,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione6,9-Aea-biqdoPixantronaF5SXN2KNMRBBR-27786,9-bis((2-aminoethyl)amino)benzo[g]isoquinoline-5,10-dioneBBR27786,9-Bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dioneBenz[g]isoquinoline-5,10-dione, 6,9-bis[(2-aminoethyl)amino]-
이름 더 보기
픽산트론CS-1359Pixantrone, BBR 2778BBR 2778Pixantrone diformate salt6,9-Bis[(2-aminoethyl)amino]benz[g]isoquinoline-5,10-dione
DTXSID101627445,8-Bis((2-aminoethyl)amino)-2-aza-anthracene-9,10-dioneBenz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-pixantronum6,9-bis(2-aminoethylamino)benzo(g)isoquinoline-5,10-dioneRefChem:929364DTXCID1085235SID225144373

데이터베이스 식별자

CAS
144510-96-3、144675-97-8
PubChem CID
134019
DTXSID
DTXSID10162744
ChEMBL
CHEMBL167731
ChEBI
CHEBI:135945
UNII
F5SXN2KNMR
EC Number
680-661-5
Nikkaji
J580.321G

물성

구조 계산 물성

XLogP
1
극성 표면적
123 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
7
회전 가능 결합 수
6
무거운 원자 수
24
형식 전하
0
복잡도
472

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15

물리화학적 성질

녹는점
173 °C · >173°C (dec.)
끓는 점
650 · 650.0±55.0 °C(Predicted)
밀도
1.405 · 1.405
저장 조건
Refrigerator
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
9.34 · 9.34±0.10(Predicted)
물리적 상태
고체
색상
진한 파란색에서 매우 진한 파란색까지

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H300 (50%): Fatal if swallowed [Danger Acute toxicity, oral]

P203, P260, P262, P264, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P308+P316, P316, P318, P320, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 2 (50%)

안전 데이터

신호 어
Warning
유해·위험 문구
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H302

화학 및 산업

약리 정보

ATC Code · 2건

L - Antineoplastic and immunomodulating agents

QL - Antineoplastic and immunomodulating agents

Protein BindingAnthracyclines, which may be effective second line treatments for NHL have limited use in therapy because of cumulative cardiotoxicity which may result in irreversible damage to cardiac tissue. [2]
Pharmacodynamics · 1건

Pixantrone has a wide range of antitumor activity, especially in terms of treating leukemias and lymphomas [3]. Pixantrone lacks cardio-toxic effects. It has postulated that his is because of its redox inactivity and lack and inhibition of doxorubicinol formation in human myocardium. [3]

Mechanism of Action · 1건

Pixantrone is an aza-anthracenedione which acts as a DNA intercalator. By intercalating between DNA, with modest affinity, it stimulates DNA cleavage by topoisomerase II. (Pixantrone acts as a poison to topoisomerase II by stabilizing protein-DNA complexes which are usually transient, giving rise to double stranded DNA breaks.) However, pixantrone is believed to have additional mechanisms of action as its potency does not correlate to the degree of double stranded DNA breaks observed. It has been postulated that this second mechanism may be pixantrone-DNA adduct formation. [1] It is important to note that the formation of a pixtantrone-DNA adduct requires pixantrone activation by formaldehyde. Formadehyde may be generated in vitro by hydrogen peroxide, and is derived by various sources in biological systems. It is present in low levels as a result of normal metabolism, and may be present in elevated levels in some haematolgical malignancies. [1] The formation of pixantrone-DNA adducts is thus feasible, and it is believed that a long pixantrone-DNA adduct half life has the potential to maximize DNA damage. It may do so by enhancing the disruption of DNA replication and transcription, and potentially by encourage apoptosis. [1] In explanation of pixantrones lack of cardiotoxicity, it has been elucidated that pixantrone is structurally similar to mitoxantrone; however, instead of a 5,8-dihydroxyphenyl ring (thought to be responsible for cardiotoxicity) it has a nitrogen heteroatom. This nitrogen heteroatom helps to create additional hydrogen bonding sites amd increases pixantrone interaction with DNA and topoisomerase II. [2] Pixantrone's lack of a hydroquinone is believed to render it resistant to one electron reduction. In contrast, doxorubicin - which contains a hydroquinone - experiences one electron redox cycling and ROS formation via NADH dehydrogenase. [3] Pixantrone also does not bind iron, and thus does not produce ROS by redox cycling between oxidative states of iron, as other anthracyclines do. [2] The first line agent doxorubicin is cardiotoxic, in part, due to its ability to redox activate the superoxide anion and hydrogen peroxide, and form a long-lived secondary alcohol metabolite: doxorubicinol. [3] Clearance of doxorubicin from myocardial tissue is incomplete, and it can be found months or years after the last administration. [3] In doxorubicin treated ex vivo cardiac strips, pixantrone formed an N-dealkylated product that inhibited metabolism of residual doxorubicin into doxorubicinol. Additionally, in ex vivo human myocardial strips (doxorubicin naive, and doxorubicin pretreated) pixantrone showed high cardiac uptake without formation of superoxide anion or hydrogen peroxide. Pixantrones lack of cardiotoxicity is thus attributed to its redox inactivity and inhibition of doxorubicinol formation. [3]

Biological Half-LifeHalf life ranges from 14.7 to 31.9 hours.
Metabolism/Metabolites · 1건

Pixantrone does not form secondary alcohol metabolites. [2] Pixantrone hydrolyzes extensively to CT-45886 which is believed to inhibit doxol formation by displacing DOX from the active site of reductases. CT4889 and CT-45890 are also formed.[3]

MeSH Pharmacological Classification · 1건

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and Excretion · 4건

Intravenous administration results in a rapid distribution followed by a slow elimination. [2] In ex vivo myocardial strips, pixantrone is taken up to a higher degree than mitoxantrone. In myocardial strips which are doxorubicin naive pixantrone displays higher uptake than in DOX-loaded myocardial strips. DOX clearance causes membrane effects which may be responsible for this observation. DOX clearance involves rapid passive diffusion through one side of the membrane followed by "flip flop" reorientation of the lipid bilayer. This disorganization of lipids is believed to impair membrane penetration by pixantrone. [3]

Fecally and renally excreted. Urinary elimination of unchanged drug is less than 10%. [2]

9.7-29.7 L/kg. [2]

Plasma clearance is 0.75 - 1.31 L/h/kg. [2]

응용 분야 · 2건

개요In May 2012, pixantrone was approved by the European Commission as a single agent for the treatment of relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL) in adult patients who have failed on at least two previous therapies. Pixantrone (also known as BBR- 2778) is an anthracycline analogue that was specifically designed to address the cardiotoxicity seen in earlier agents by replacement of a 1,4- dihydroxyanthracene-9,10-dione core with a benzoisoquinoline-5,10-dione ring system. Pixantrone inhibits topoisomerase II by intercalation with DNA and is also believed to form covalent adducts with the N-2 amino group of guanine via a formaldehyde aminal formed with the primary amino groups. Pixantrone is less cytotoxic than other anthracycline derivatives, but shows good antitumor activity in vivo in a variety of preclinical tumor models, including leukemia and lymphoma models. Pixantrone also demonstrated significantly reduced cardiotoxicity in preclinical models compared with the anthracyclines doxorubicin and mitroxantrone. Pixantrone was synthesized by Friedel–Crafts reaction of pyridine-3,4-dicarboxylic acid anhydride with 1,4-difluorobenzene to give a ketoacid that was cyclized to the tricyclic core by treatment with fuming sulfuric acid at 140℃. Reaction of the resulting 6,9-difluorobenzoisoquinoline-5-10-dione with ethylenediamine followed by careful pH adjustment and treatment with maleic acid gave pixantrone in good overall yield and purity.

용도Pixantrone is an antineoplastic drug belonging to group of antitumor antibiotics. Pixantrone is an anlogue of Mitoxantrone (M373425) and is just as potent in the treatment of multiple sclerosis with fewer toxic effects on cardiac tissue. Studies suggest that Pixantrone significantly reduces amyloid beta (A beta(1-42)) neurotoxicity, a mechanism implicated in Alzheimer's disease.

상·하류 제품 정보

상류 원료

Benz[g]isoquinoline-5,10-dione, 6,9-dihydroxy-6,9-디플루오로벤조이소퀴놀린-5,10-디온3,4-피리딘디카르복실릭 안하이드리드에틸렌디아민3,4-피리딘디카르복시산

관련 반응

8건
반응 기록 만들기
HRID 52402 반응식
HRID 52402생성물로
HRID 269708 반응식
HRID 269708반응물로
HRID 862158 반응식
HRID 862158생성물로
HRID 862162 반응식
HRID 862162생성물로
HRID 862163 반응식
HRID 862163생성물로
HRID 862164 반응식
HRID 862164반응물로
HRID 1720233 반응식
HRID 1720233생성물로
HRID 1720236 반응식
HRID 1720236생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트